Acadia Pharmaceuticals buy Cantor Fitzgerald
Start price
30.04.24
/
50%
€15.79
Target price
30.04.25
€34.52
Performance (%)
-12.32%
Price
29.05.24
€13.54
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -12.32%. This prediction currently runs until 30.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -3.458% | -3.458% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€34.35
09.05.25
09.05.25
-7.20%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
10.04.24
10.04.24
€34.38
10.04.25
10.04.25
-17.94%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
28.02.24
28.02.24
€38.75
28.02.25
28.02.25
-37.89%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.60
02.02.24
02.02.24
€38.87
02.02.25
02.02.25
-42.63%
29.05.24
29.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
14.12.23
14.12.23
€38.21
14.12.24
14.12.24
-47.11%
29.05.24
29.05.24